CN102210821A - Traditional Chinese medicine for treating xerophthalmia - Google Patents
Traditional Chinese medicine for treating xerophthalmia Download PDFInfo
- Publication number
- CN102210821A CN102210821A CN2011101373890A CN201110137389A CN102210821A CN 102210821 A CN102210821 A CN 102210821A CN 2011101373890 A CN2011101373890 A CN 2011101373890A CN 201110137389 A CN201110137389 A CN 201110137389A CN 102210821 A CN102210821 A CN 102210821A
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- root
- treatment
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the field of traditional Chinese medicine, in particular to a traditional Chinese medicine for treating xerophthalmia, characterized by comprising the following medicinal raw materials: 6-9g of astragalus root, 8-10g of coix seed, 3-6g of peony, 6-9g of angelica, 6-9g of prepared rehmannia root, 3-6g of dodder, 4-6g of sealwort, 5-6g of magnolia vine fruit, 6-9g of figwort, 3-6g of rehmannia root, 3-6g of tree peony bark, 3-6g of lily, 3-6g of root of straight ladybell, 3-6g of ophiopogon root, 3-6g of polygonatum and 3-6g of licorice. Chinese traditional treatment for the disease has the therapeutic principles of nourishing the liver, tonifying the kidney, eliminating pathogenic heat from the blood, nourishing yin and moistening dryness, and diagnosis and treatment are based on an overall analysis of the illness and the condition of a patient according to different symptoms clinically. The medicine is simple to prepare and convenient to use, and has low cost, wide medicine sources, quick curative effect, high cure rate and no toxic side effect.
Description
Technical field
The present invention relates to tcm field, specifically a kind of Chinese medicine for the treatment of xerophthalmia.
Background technology
Xerophthalmia is one of common ophthalmic diseases, owing to multiple reason makes eyeball surface water quality, mucus and the lipid secretion back tear quality and quantity disequilibrium that causes a series of syndromes takes place.Clinical manifestation is sensation of dryness, foreign body sensation, gargalesthesia, photophobia, furious, and blurred vision, vision fluctuation, asthenopia etc. belong to the traditional Chinese medical science " dry disease " scope.At present, eye drop eye drip commonly used can increase the lubricated cornea of water liquid or stimulate effect such as lacrimal secretion, but the respite symptom, but prolonged application weak effect not only, but also have toxic and side effects, unfavorable to vision.
The Chinese traditional treatment primary disease, with liver-nourishing kidney-boosting, clearing away heat and cooling blood, nourshing Yin and drynsessmoistening prescription be the rule of treatment.Clinically often according to different pattern of syndrome determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs.
Summary of the invention
The present invention seeks to provides good effect, short treating period, cure rate height in order to solve above-mentioned technical deficiency, the low and a kind of Chinese medicine for the treatment of xerophthalmia that has no side effect of cost.
For achieving the above object, a kind of Chinese medicine for the treatment of xerophthalmia is characterized in that the crude drug of Chinese medicine consists of: the Radix Astragali 6～9g, Semen Coicis 8～10g, Radix Paeoniae 3～6g, Radix Angelicae Sinensis 6～9g, Radix Rehmanniae Preparata 6～9g, Semen Cuscutae 3～6g, Rhizoma Polygonati 4～6g, Fructus Schisandrae Chinensis 5～6g, Radix Scrophulariae 6～9g, the Radix Rehmanniae 3～6g, Cortex Moutan 3～6g, Bulbus Lilii 3～6g, Radix Adenophorae (Radix Glehniae) 3～6g, Radix Ophiopogonis 3～6g, Rhizoma Polygonati Odorati 3～6g, Radix Glycyrrhizae 3～6g.
Chinese medicine preparation of the present invention is simple, cost is low, the medicine source is wide, easy to use, curative effect is fast, and the cure rate height is without any side effects.
Radix Astragali sweet in the mouth among the present invention, temperature.Return lung, spleen channel.Effect: QI invigorating, granulation promoting, detumescence, diuretic contain various trace elements, mend all empty not enough, tools and mend and oiliness characteristics.Function with enhancing body reticular system.Semen Coicis is cool in nature, sweet in the mouth, light.Effect: function with spleen invigorating eliminating dampness by diuresis, clearing away heat and discharging pus, eliminating impediment, diuretic.Radix Paeoniae bitter in the mouth, acid, cold nature.Effect: suppressing the hyperactive liver pain relieving, nourishing blood for regulating menstruation, astringing YIN to stop sweating.The Radix Rehmanniae Preparata sweet in the mouth; Warm in nature.Return liver, kidney channel.Effect: moist, the beneficial essence of enriching blood is filled out marrow.Semen Cuscutae effect the kidney invigorating and essence nourishing, nourishing the liver detoxifcation.The Rhizoma Polygonati sweet in the mouth is flat.Return lung spleen kidney channel.Has boosting qi and nourishing yin, spleen invigorating, lung moistening, kidney benefiting functions.Fructus Schisandrae Chinensis flavor temperature; Sour, sweet; Return lung, the heart, kidney channel.Effect: restrain astringent or styptic treatment for spontaneous sweating, supplementing QI for promoting the production of body fluid, kidney calming.Radix Scrophulariae is cold in nature, bitter in the mouth, sweet, salty.Return lung, stomach, kidney channel.Effect: heat clearing away, detoxifcation, yin nourishing, softening the hard mass.Radix Rehmanniae sweet in the mouth, hardship, cold.GUIXIN, liver, kidney channel.The effect clearing away heat and cooling blood, yin nourishing is promoted the production of body fluid.Be used for calentura crimson tongue excessive thirst, interior-heat caused by deficiency of YIN.The Cortex Moutan cold nature, bitter in the mouth, suffering.GUIXIN, liver, kidney channel.Effect: clearing away heat and cooling blood, promoting blood circulation to remove blood stasis.The Cortex Moutan clearing away heat and cooling blood, the branch of dehematizing is hot and suffocating and the effect of removing blood stasis dissipating rashes, hemostasis is arranged.The sweet cold of Bulbus Lilii is clear and rich, and the master goes into the lung heart, effect: clearing away lung-heat and moistening for dryness, clearing away heart-fire for tranquillization arresting convulsion.Radix Adenophorae (Radix Glehniae) bitter in the mouth is slightly cold, and is nontoxic.Effect: have the merit Rhizoma Polygonati Odorati sweet in the mouth of Yin-nourishing and body fluid promoting, clearing away heat and cooling blood, flat.Go into lung, stomach warp.The effect yin nourishing is moisturized, and relieving restlessness is quenched the thirst.Radix Glycyrrhizae is distinguished the flavor of little sweet, is tonic.Effect: invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.
The present invention follows the prescription principle of medication of the traditional Chinese medical science, and the usefulness that is decocted in water for oral dose is whenever taken medicine and fried in shallow oil 2 times 1 dose of every day, fries in shallow oil 200ml altogether, and verify through clinical application for many years: effective percentage is more than 95%, and cure rate is more than 85%.Instruct the patient away from electric radiation times such as computer, TV, mobile phone more than 2 months.
The specific embodiment
Below in conjunction with implementing case the present invention is further described:
Implement 1: a kind of Chinese medicine for the treatment of xerophthalmia is characterized in that by following proportioning weighting raw materials thing: the Radix Astragali 6～9g, Semen Coicis 8～10g, Radix Paeoniae 3～6g, Radix Angelicae Sinensis 6～9g, Radix Rehmanniae Preparata 6～9g, Semen Cuscutae 3～6g, Rhizoma Polygonati 4～6g, Fructus Schisandrae Chinensis 5～6g, Radix Scrophulariae 6～9g, the Radix Rehmanniae 3～6g, Cortex Moutan 3～6g, Bulbus Lilii 3～6g, Radix Adenophorae (Radix Glehniae) 3～6g, Radix Ophiopogonis 3～6g, Rhizoma Polygonati Odorati 3～6g, Radix Glycyrrhizae 3～6g.
Cure rate is more than 85%, and effective percentage is more than 95%.
Implement 2: a kind of Chinese medicine for the treatment of xerophthalmia, its preferred side is: Radix Astragali 9g, Semen Coicis 9g, Radix Paeoniae 6g, Radix Angelicae Sinensis 9g, Radix Rehmanniae Preparata 9g, Semen Cuscutae 6g, Rhizoma Polygonati 6g, Fructus Schisandrae Chinensis 6g, Radix Scrophulariae 9g, Radix Rehmanniae 6g, Cortex Moutan 6g, Bulbus Lilii 6g, Radix Adenophorae (Radix Glehniae) 6g, Radix Ophiopogonis 6g, Rhizoma Polygonati Odorati 3g, Radix Glycyrrhizae 3g.
Clinical efficacy is summed up:
One, physical data
Chinese medicine of the present invention is used for many years clinically, treatment patient examples up to a hundred, and particularly because of TV, computer, mobile phone, and the xerophthalmia hepatic and renal YIN deficiency patient effect that climacteric women causes is better, and has no side effect.
Two, diagnostic criteria: multiple reason comprises that eyeball surface water quality, mucus and the back institute of lipid secretion that computer, TV, the radiation of mobile phone point or Woman climacteric cause cause tear quality and quantity disequilibrium and a series of syndromes take place.Clinical manifestation is sensation of dryness, foreign body sensation, gargalesthesia, photophobia, furious, and blurred vision, vision fluctuation, asthenopia etc. have caused the tear downgrade.Have a medical check-up: the lacrimal secretion test is positive.
Three, method of administration: every dose of decocting 200ml, 1 dose of every day, early, late sub-service, 15 days was 1 course of treatment.
Four, curative effect judging standard:
Cure: the symptom complete obiteration; ,
Take a turn for the better: sx;
Invalid: clinical symptoms does not have improvement, even the person of increasing the weight of.
Five, therapeutic effect: taking medicine 15 days is a course of treatment, and 1 course of treatment of light disease is a transference cure, the complete obiteration that disappears of the serious symptom 2-3 symptom course of treatment.Effective percentage is more than 95% by statistics, and cure rate is more than 85%.
Six, model case
1, old X, the man, 16 years old, the student,, foreign body sensation dry and astringent because of eye, 1 week of photophobia, through examining in April, 2009 with the Runshu eye drops poor effect, have a medical check-up: eye is in conjunction with congested, cornea film drying, the lacrimal secretion test is positive.The patient requires to obey 20 doses in this Chinese medicine, the symptom complete obiteration, and lacrimal secretion test is normal, continues away from computer, TV 2 months recurrence so far.
2, open XX, the woman, 19 years old, dry and astringent, the blurred vision of eye, visual deterioration, asthenopia were examined in January, 2010.Have a medical check-up: have a medical check-up: the eyes distending pain, conjunctival congestion, lachrymal gland is narrow slightly, and intraocular pressure is normal, and the lacrimal secretion test is positive.Through taking 30 doses of the present invention, and stimulated 3 months away from electric radiation, the symptom complete obiteration, the lacrimal secretion test is normal, so far recurrence again.
3, patient clump XX, the woman, 51 years old, the retired worker, the patient did not get better to change in December in 2010 and examined in 21st because of sensation of dryness, foreign body sensation, gargalesthesia, photophobia once are coated with erythromycin eye ointment.Have a medical check-up: conjunctival xerosis, the lacrimal secretion test is positive.Through taking 15 doses of the present invention, sings and symptoms complete obiteration, not recurrence more so far.
Claims (2)
1. the Chinese medicine of a treatment is characterized in that it is made up of the component of following weight material medicine proportioning: the Radix Astragali 6～9g, Semen Coicis 8～10g, Radix Paeoniae 3～6g, Radix Angelicae Sinensis 6～9g, Radix Rehmanniae Preparata 6～9g, Semen Cuscutae 3～6g, Rhizoma Polygonati 4～6g, Fructus Schisandrae Chinensis 5～6g, Radix Scrophulariae 6～9g, the Radix Rehmanniae 3～6g, Cortex Moutan 3～6g, Bulbus Lilii 3～6g, Radix Adenophorae (Radix Glehniae) 3～6g, Radix Ophiopogonis 3～6g, Rhizoma Polygonati Odorati 3～6g, Radix Glycyrrhizae 3～6g.
2. the Chinese medicine of a kind of treatment according to claim 1, its preferred side be Radix Astragali 9g, Semen Coicis 9g, Radix Paeoniae 6g, Radix Angelicae Sinensis 9g, Radix Rehmanniae Preparata 9g, Semen Cuscutae 6g, Rhizoma Polygonati 6g, Fructus Schisandrae Chinensis 6g, Radix Scrophulariae 9g, Radix Rehmanniae 6g, Cortex Moutan 6g, Bulbus Lilii 6g, Radix Adenophorae (Radix Glehniae) 6g, Radix Ophiopogonis 6g, Rhizoma Polygonati Odorati 3g, Radix Glycyrrhizae 3g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110137389A CN102210821B (en) | 2011-05-15 | 2011-05-15 | Traditional Chinese medicine for treating xerophthalmia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110137389A CN102210821B (en) | 2011-05-15 | 2011-05-15 | Traditional Chinese medicine for treating xerophthalmia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102210821A true CN102210821A (en) | 2011-10-12 |
| CN102210821B CN102210821B (en) | 2012-10-24 |
Family
ID=44742505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110137389A Expired - Fee Related CN102210821B (en) | 2011-05-15 | 2011-05-15 | Traditional Chinese medicine for treating xerophthalmia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102210821B (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102824547A (en) * | 2012-09-20 | 2012-12-19 | 于耀光 | Traditional Chinese medicine ultrasonic atomization agent for treating xerophthalmia and preparation method thereof |
| CN102920911A (en) * | 2012-12-05 | 2013-02-13 | 胡海波 | Chinese medicament for treating keratoconjunctivitis sicca and preparation method thereof |
| CN102973842A (en) * | 2012-12-04 | 2013-03-20 | 王亚明 | Traditional Chinese medicine fuming and washing liquid for treating xerophthalmia |
| CN103550558A (en) * | 2013-11-01 | 2014-02-05 | 袁梅 | Preparation method of medicament for treating xerophthalmia of hospital information personnel |
| CN104189445A (en) * | 2014-08-11 | 2014-12-10 | 青岛市市立医院 | Traditional Chinese medicine composition and preparation method and application thereof |
| CN104324139A (en) * | 2014-11-07 | 2015-02-04 | 王磊 | Medicine composition for treating xerophthalmia |
| CN105194279A (en) * | 2014-06-26 | 2015-12-30 | 梁军 | Drug for treating dry eye syndrome |
| CN105250725A (en) * | 2015-10-31 | 2016-01-20 | 王金环 | Traditional Chinese medicine for treating xerostomia |
| CN107158247A (en) * | 2017-06-12 | 2017-09-15 | 湖南云从科技有限公司 | It is a kind of to alleviate dry and astringent liquid medicine of eye and preparation method thereof |
| WO2019124854A1 (en) * | 2017-12-22 | 2019-06-27 | 한국한의학연구원 | Composition for preventing or treating dry eye syndrome, containing mixed extract or fraction thereof |
-
2011
- 2011-05-15 CN CN201110137389A patent/CN102210821B/en not_active Expired - Fee Related
Non-Patent Citations (2)
| Title |
|---|
| 李影，等: "干眼症的中医药治疗近况", 《山东中医杂志》 * |
| 韦保朝，等: "中医药治疗干眼症近况", 《河北中医》 * |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102824547A (en) * | 2012-09-20 | 2012-12-19 | 于耀光 | Traditional Chinese medicine ultrasonic atomization agent for treating xerophthalmia and preparation method thereof |
| CN102973842A (en) * | 2012-12-04 | 2013-03-20 | 王亚明 | Traditional Chinese medicine fuming and washing liquid for treating xerophthalmia |
| CN102920911A (en) * | 2012-12-05 | 2013-02-13 | 胡海波 | Chinese medicament for treating keratoconjunctivitis sicca and preparation method thereof |
| CN102920911B (en) * | 2012-12-05 | 2014-05-07 | 青岛市中心医院 | Traditional Chinese medicine for treating keratoconjunctivitis sicca and preparation method thereof |
| CN103550558A (en) * | 2013-11-01 | 2014-02-05 | 袁梅 | Preparation method of medicament for treating xerophthalmia of hospital information personnel |
| CN105194279A (en) * | 2014-06-26 | 2015-12-30 | 梁军 | Drug for treating dry eye syndrome |
| CN104189445A (en) * | 2014-08-11 | 2014-12-10 | 青岛市市立医院 | Traditional Chinese medicine composition and preparation method and application thereof |
| CN104324139A (en) * | 2014-11-07 | 2015-02-04 | 王磊 | Medicine composition for treating xerophthalmia |
| CN105250725A (en) * | 2015-10-31 | 2016-01-20 | 王金环 | Traditional Chinese medicine for treating xerostomia |
| CN107158247A (en) * | 2017-06-12 | 2017-09-15 | 湖南云从科技有限公司 | It is a kind of to alleviate dry and astringent liquid medicine of eye and preparation method thereof |
| WO2019124854A1 (en) * | 2017-12-22 | 2019-06-27 | 한국한의학연구원 | Composition for preventing or treating dry eye syndrome, containing mixed extract or fraction thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102210821B (en) | 2012-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102210821B (en) | Traditional Chinese medicine for treating xerophthalmia | |
| CN103341004A (en) | Chinese medicine composition for treating delayed menstrual cycle | |
| CN104491695A (en) | Pharmaceutical composition for treating chloasma | |
| CN102423423B (en) | Traditional Chinese medicine for treating urinary tract infection | |
| CN109999164A (en) | There is the Chinese materia medica preparation of nourishing qi and blood, strengthening vital QI to eliminate pathogenic factors effect for lung cancer therapy | |
| CN106728937A (en) | A kind of Chinese medicine for treating eye illness | |
| CN103784890A (en) | Traditional Chinese medicine composition for treating bone diseases | |
| CN102908504A (en) | Chinese medicinal composition for regulating female endocrine dyscrasia | |
| CN104524071A (en) | Pharmaceutical composition for treating primary renal disease and application thereof | |
| CN103263587A (en) | Traditional Chinese medicine preparation for treating toxic and side effects of nasopharyngeal carcinoma after radiotherapy and preparation method thereof | |
| CN102716409A (en) | Traditional Chinese medicine composition for tonifying qi and nourishing blood | |
| CN104436048A (en) | Use of traditional Chinese medicine preparation in preparation of medicine for treating qi stagnation and blood stasis type chloasma | |
| CN104587127A (en) | Traditional Chinese medicine preparation for treating dysfunctional uterine bleeding and preparation method thereof | |
| CN103330854A (en) | Traditional Chinese medicine composition for treating nasal hemorrhage | |
| CN105561211A (en) | External ointment for treating mammary gland inflammation | |
| CN103845580A (en) | Traditional Chinese medicine composition for treating allergic rhinitis | |
| CN102085284B (en) | Traditional Chinese medicine for treating zoster | |
| CN105250966A (en) | Foot bath medicine for treatment of yang deficiency and preparation method and application thereof | |
| CN103705868B (en) | One treats hyperthyroid pharmaceutical composition and application thereof | |
| CN104383352A (en) | Chinese medicinal preparation for treating xerophthalmia due to deficiency of yin, dampness and heat | |
| CN102988890A (en) | Pure Chinese medicine preparation for treating chloasma | |
| CN114344378B (en) | Traditional Chinese medicine composition for treating blood deficiency and blood stasis type cervical spondylosis, preparation and application | |
| CN103169894A (en) | Traditional Chinese medicine composition for treating proteinuria | |
| CN107080811A (en) | Treat Chinese medicine preparation of whelk and preparation method thereof | |
| CN102357218B (en) | Chinese medicinal composition for treating abnormal menstruation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121024 Termination date: 20130515 |